Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Cleary

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Cancer Cell|October 19, 2006
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemiaTim C P Somervaille, Michael L Cleary
Cancer Cell|December 13, 2006
PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cellsTim C P Somervaille, Michael L Cleary
Cell Stem Cell|November 10, 2009
Preview. Mutant CEBPA: Priming Stem Cells for Myeloid LeukemogenesisTim C P Somervaille, Michael L Cleary
International Journal of Hematology|May 11, 2010
Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?Tim C P Somervaille, Michael L Cleary
Genesis (New York, N.Y. : 2000)|November 5, 2003
Pbx1 is essential for adrenal development and urogenital differentiationCatherine A Schnabel, Licia Selleri, Michael L Cleary
Developmental Biology|February 20, 2003
Pbx1 regulates nephrogenesis and ureteric branching in the developing kidneyCatherine A Schnabel, Robert E Godin, Michael L Cleary
Molecular and Cellular Biology|October 9, 2002
Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2Kevin S Smith, Joon Whan Rhee, Michael L Cleary
Molecular and Cellular Biology|November 16, 2004
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoproteinPaul M Ayton, Everett H Chen, Michael L Cleary
Plos One|November 21, 2015
Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In MiceJesús Duque-Afonso, Kevin S Smith, Michael L Cleary
Cell Stem Cell|September 22, 2015
CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid LeukemiaMasayuki Iwasaki, Michaela Liedtke, Andrew J Gentles, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Cancer Cell|October 19, 2006
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemiaTim C P Somervaille, Michael L Cleary
Cancer Cell|December 13, 2006
PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cellsTim C P Somervaille, Michael L Cleary
Cell Stem Cell|November 10, 2009
Preview. Mutant CEBPA: Priming Stem Cells for Myeloid LeukemogenesisTim C P Somervaille, Michael L Cleary
International Journal of Hematology|May 11, 2010
Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?Tim C P Somervaille, Michael L Cleary
Genesis (New York, N.Y. : 2000)|November 5, 2003
Pbx1 is essential for adrenal development and urogenital differentiationCatherine A Schnabel, Licia Selleri, Michael L Cleary
Developmental Biology|February 20, 2003
Pbx1 regulates nephrogenesis and ureteric branching in the developing kidneyCatherine A Schnabel, Robert E Godin, Michael L Cleary
Molecular and Cellular Biology|October 9, 2002
Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2Kevin S Smith, Joon Whan Rhee, Michael L Cleary
Molecular and Cellular Biology|November 16, 2004
Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoproteinPaul M Ayton, Everett H Chen, Michael L Cleary
Plos One|November 21, 2015
Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In MiceJesús Duque-Afonso, Kevin S Smith, Michael L Cleary
Cell Stem Cell|September 22, 2015
CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid LeukemiaMasayuki Iwasaki, Michaela Liedtke, Andrew J Gentles, et al.
Pageof 10